News

Published on 9 May 2024 on Insider Monkey via Yahoo Finance

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript


Article preview image

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript May 8, 2024

Karyopharm Therapeutics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good morning. My name is Liz [ph] and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Karyopharm Therapeutics First Quarter 2024 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Elhan Webb, Senior Vice President, Investor Relations.

NASDAQ.KPTI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating...

Karyopharm Therapeutics Inc (KPTI) reports steady revenue growth and promising pipeline...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of...

Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to release its Q3 2024 earnings on Nov 5, 2024. ...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

Highbridge Capital Management's Strategic Acquisition of Karyopharm Therapeutics...

On September 30, 2024, Highbridge Capital Management LLC made a significant move in the stock mar...

GuruFocus.com · via Yahoo Finance 25 Oct 2024

Karyopharm Therapeutics Inc. (KPTI): Is This One-Dollar Stock a Strong Buy Right...

We recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are...

Insider Monkey · via Yahoo Finance 21 Jul 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript May 8, 2024 Karyophar...

Insider Monkey via Yahoo Finance 9 May 2024

Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...

President and CEO Richard Paulson executed a sale of 99,844 shares of Karyopharm Therapeutics Inc...

GuruFocus.com via Yahoo Finance 4 Mar 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Kar...

Insider Monkey via Yahoo Finance 1 Mar 2024

Karyopharm Therapeutics: Q4 Earnings Snapshot

Karyopharm Therapeutics: Q4 Earnings Snapshot

Washington Post 29 Feb 2024

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $0.36 per share versus the Zacks...

Zacks via Yahoo Finance 29 Feb 2024

Karyopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though...

It is a pleasure to report that the Karyopharm Therapeutics Inc. (NASDAQ:KPTI) is up 139% in the ...

Simply Wall St. via Yahoo Finance 7 Feb 2024